Breaking
Friday, June 19, 2026
🇺🇸 Americas · Directory profile

Multiply Labs

Robotic Biomanufacturing Systems

Visit website

Company overview

Multiply Labs develops cloud-controlled modular robotic systems that automate biomanufacturing for cell and gene therapies, integrating with GMP instruments for high-throughput production. These systems enable scalable manufacturing of personalized therapies in pharma facilities, reducing costs by up to 74% and minimizing contamination risks. They collaborate with leaders like AstraZeneca, Thermo Fisher, and NVIDIA to deploy robotics in cleanrooms for precision medicine.

Multiply Labs is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing, Lab Equipment & Instruments partner serving United States & Americas. Core focus areas include robotic biomanufacturing, cell therapy automation, gene therapy robots, gmp robotics, pharma manufacturing systems.

Industry categories: CDMO & Manufacturing, Lab Equipment & Instruments. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.

Products and technologies associated with Multiply Labs include Automation — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.

Structured facts

Website
https://www.multiplylabs.com
Categories
CDMO & Manufacturing, Lab Equipment & Instruments
Markets served
United States & Americas
Keywords
robotic biomanufacturing, cell therapy automation, gene therapy robots, gmp robotics, pharma manufacturing systems

Products & technologies

  • Automation

Therapeutic areas

  • Gene Therapy
  • Cell Therapy

Markets served

  • United States & Americas

Industry categories

Company timeline

  1. — Profile published on NovaPharmaNews
  2. — Profile last updated

Related suppliers in category

Frequently asked questions

What manufacturing capabilities does Multiply Labs offer?
Cloud-controlled modular robotic systems for automating cell and gene therapy production, integrating GMP instruments for high-throughput, parallel processing of personalized therapies.
Are Multiply Labs' systems GMP-compliant and regulatory-ready?
Yes, their robotic biomanufacturing systems are GMP-ready, designed for clinical and commercial-scale use while maintaining quality and regulatory standards.
What geographies does Multiply Labs serve?
Based in San Francisco, CA, they deploy systems in pharma customer facilities worldwide, partnering with global companies like AstraZeneca and Thermo Fisher Scientific.